Načítá se...
Aflibercept versus ranibizumab for treating persistent diabetic macular oedema
The purpose of this study was to compare the efficacy of intravitreal aflibercept versus ranibizumab for treating therapy-resistant diabetic macular oedema (DME). A 69-year-old man presented with persistent bilateral DME despite previous ranibizumab treatment. Bilateral study treatment comprised one...
Uloženo v:
| Vydáno v: | Int Ophthalmol |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Netherlands
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4488481/ https://ncbi.nlm.nih.gov/pubmed/25989873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10792-015-0081-7 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|